Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
| Image |  |
|---|---|
| Description | scientific article published in July 1998 |
| Author/s | |
| Publication date | July 1, 1998 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |